Research never stops

High-throughput screening

Evotec has a long history in high-throughput screening (“HTS”) utilising large client compound collections and also our own 400,000 compound collection together with the exclusive access to the Sanofi library of 700,000 molecules. Evotec’s screening platform is differentiated through integrating a variety of detection technologies with high-throughput capabilities. This technology platform allows for assay miniaturisation and use of multiple read-out parameters to enable the reduction of false positives and negatives. Evotec’s technology platform includes nuclear magnetic resonance spectrometry (“NMR”), surface plasmon resonance spectrometry (“SPR”), high-content screening (“HCS”), high-throughput mass spectrometry based screening (“HTMS”) and high-throughput RT-qPCR.

For more detailed information, please click on this link or contact us at info@evotec.com.

High-throughput screening